SFE Investment Counsel’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,691
| Closed | -$358K | – | 116 |
|
|
2024
Q3 | $358K | Sell |
5,691
-9,439
| -62% | -$551K | 0.07% | 106 |
|
|
2024
Q2 | $894K | Sell |
15,130
-54,314
| -78% | -$3.4M | 0.2% | 85 |
|
|
2024
Q1 | $5.54M | Buy |
69,444
+4,561
| +7% | +$348K | 1.26% | 28 |
|
|
2023
Q4 | $5.12M | Buy |
64,883
+4,431
| +7% | +$315K | 1.33% | 28 |
|
|
2023
Q3 | $4.22M | Buy |
60,452
+14,861
| +33% | +$1.05M | 1.23% | 33 |
|
|
2023
Q2 | $3.15M | Buy |
45,591
+21,835
| +92% | +$1.55M | 0.89% | 42 |
|
|
2023
Q1 | $1.73M | Buy |
23,756
+5,841
| +33% | +$490K | 0.53% | 61 |
|
|
2022
Q4 | $1.57M | Sell |
17,915
-1,255
| -7% | -$121K | 0.49% | 61 |
|
|
2022
Q3 | $1.83M | Sell |
19,170
-3,975
| -17% | -$393K | 0.58% | 57 |
|
|
2022
Q2 | $2.15M | Sell |
23,145
-115
| -0.5% | -$11.2K | 0.64% | 55 |
|
|
2022
Q1 | $2.35M | Sell |
23,260
-625
| -3% | -$65.7K | 0.6% | 56 |
|
|
2021
Q4 | $2.46M | Sell |
23,885
-268
| -1% | -$24.8K | 0.63% | 52 |
|
|
2021
Q3 | $2.05M | Sell |
24,153
-2,007
| -8% | -$168K | 0.57% | 55 |
|
|
2021
Q2 | $2.18M | Sell |
26,160
-15
| -0.1% | -$1.23K | 0.6% | 54 |
|
|
2021
Q1 | $1.97M | Sell |
26,175
-405
| -2% | -$29.5K | 0.57% | 55 |
|
|
2020
Q4 | $1.81M | Sell |
26,580
-7,502
| -22% | -$488K | 0.58% | 52 |
|
|
2020
Q3 | $1.99M | Buy |
34,082
+1,617
| +5% | +$101K | 0.79% | 44 |
|
|
2020
Q2 | $2.11M | Sell |
32,465
-1,140
| -3% | -$71.8K | 0.93% | 39 |
|
|
2020
Q1 | $1.99M | Sell |
33,605
-360
| -1% | -$24K | 1.1% | 33 |
|
|
2019
Q4 | $2.52M | Sell |
33,965
-2,630
| -7% | -$185K | 1.03% | 32 |
|
|
2019
Q3 | $2.31M | Buy |
36,595
+8,690
| +31% | +$515K | 0.98% | 36 |
|
|
2019
Q2 | $1.52M | Buy |
27,905
+20,535
| +279% | +$1.11M | 0.65% | 50 |
|
|
2019
Q1 | $397K | Buy |
+7,370
| New | +$455K | 0.18% | 90 |
|
|
2018
Q4 | – | Sell |
-2,720
| Closed | -$214K | – | 120 |
|
|
2018
Q3 | $214K | Sell |
2,720
-1,625
| -37% | -$116K | 0.08% | 122 |
|
|
2018
Q2 | $280K | Sell |
4,345
-17,227
| -80% | -$1.14M | 0.12% | 115 |
|
|
2018
Q1 | $1.34M | Sell |
21,572
-3,803
| -15% | -$273K | 0.7% | 43 |
|
|
2017
Q4 | $1.84M | Buy |
25,375
+9,890
| +64% | +$719K | 0.74% | 44 |
|
|
2017
Q3 | $1.26M | Sell |
15,485
-3,370
| -18% | -$267K | 0.53% | 59 |
|
|
2017
Q2 | $1.52M | Sell |
18,855
-1,919
| -9% | -$152K | 0.62% | 50 |
|
|
2017
Q1 | $1.63M | Buy |
+20,774
| New | +$1.66M | 0.6% | 50 |
|
Other funds holding CVS
SFE Investment Counsel's CVS Position: Q4 2024 in Review
SFE Investment Counsel sold out of CVS Health (CVS) in Q4 2024, closing a stake of 5,691 shares — an estimated $358K sold.
SFE Investment Counsel first reported a position in CVS in Q1 2017 and held it in 30 quarters. The position peaked at $5.54M in Q1 2024. 1,669 funds tracked by Wall St. Rank hold CVS as of Q4 2024.
- SFE Investment Counsel reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
- SFE Investment Counsel sold 5,691 CVS Health shares in Q4 2024, an estimated $358K.
- SFE Investment Counsel first reported a position in CVS Health in Q1 2017 and held it in 30 quarters.
- SFE Investment Counsel's CVS Health position peaked at $5.54M in Q1 2024.
- 1,669 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.
Based on SFE Investment Counsel's 13F filing for Q4 2024, filed 30 Jan 2025.